{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:01:05Z","timestamp":1787022065793,"version":"build-2736575974"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T00:00:00Z","timestamp":1590105600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0233213","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T13:29:08Z","timestamp":1590154148000},"page":"e0233213","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6066-8614","authenticated-orcid":true,"given":"Shosha E. I.","family":"Dekker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin","family":"Verhoeven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darius","family":"Soonawala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien J. M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan W.","family":"de Fijter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleg A.","family":"Mayboroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the DIPAK Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,5,22]]},"reference":[{"issue":"Suppl 4","key":"pone.0233213.ref001","doi-asserted-by":"crossref","first-page":"iv15","DOI":"10.1093\/ndt\/gfu017","article-title":"Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe: prevalence and survival\u2014an analysis of data from the ERA-EDTA Registry","volume":"29","author":"EM Spithoven","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"pone.0233213.ref002","first-page":"1356","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"32","author":"CJ Willey","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"pone.0233213.ref003","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1093\/ndt\/gfv456","article-title":"Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice","volume":"31","author":"RT Gansevoort","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"25","key":"pone.0233213.ref004","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","article-title":"Tolvaptan in patients with autosomal dominant polycystic kidney disease","volume":"367","author":"VE Torres","year":"2012","journal-title":"The New England journal of medicine"},{"key":"pone.0233213.ref005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/978-981-10-2041-4_8","article-title":"Diagnostic Evaluation as a Biomarker in Patients with ADPKD","volume":"933","author":"HC Park","year":"2016","journal-title":"Adv Exp Med Biol"},{"issue":"7","key":"pone.0233213.ref006","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2018121227","article-title":"Soluble Urokinase Plasminogen Activator Receptor and Decline in Kidney Function in Autosomal Dominant Polycystic Kidney Disease","volume":"30","author":"SS Hayek","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"pone.0233213.ref007","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/nrneph.2011.152","article-title":"Metabolomics in the study of kidney diseases","volume":"8","author":"RH Weiss","year":"2011","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"pone.0233213.ref008","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.kint.2016.08.021","article-title":"An overview of renal metabolomics","volume":"91","author":"S Kalim","year":"2017","journal-title":"Kidney Int"},{"issue":"1","key":"pone.0233213.ref009","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4161\/org.24322","article-title":"Applications of metabolomics for kidney disease research: from biomarkers to therapeutic targets","volume":"9","author":"HI Wettersten","year":"2013","journal-title":"Organogenesis"},{"issue":"11","key":"pone.0233213.ref010","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data","volume":"29","author":"JK Nicholson","year":"1999","journal-title":"Xenobiotica"},{"issue":"2","key":"pone.0233213.ref011","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrd728","article-title":"Metabonomics: a platform for studying drug toxicity and gene function","volume":"1","author":"JK Nicholson","year":"2002","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"pone.0233213.ref012","doi-asserted-by":"crossref","first-page":"e73076","DOI":"10.1371\/journal.pone.0073076","article-title":"The human urine metabolome","volume":"8","author":"S Bouatra","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"pone.0233213.ref013","doi-asserted-by":"crossref","first-page":"F909","DOI":"10.1152\/ajprenal.00722.2009","article-title":"A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease","volume":"298","author":"SL Taylor","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"issue":"11","key":"pone.0233213.ref014","doi-asserted-by":"crossref","first-page":"e1003053","DOI":"10.1371\/journal.pgen.1003053","article-title":"Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4alpha as a disease modifier","volume":"8","author":"LF Menezes","year":"2012","journal-title":"PLoS Genet"},{"issue":"2","key":"pone.0233213.ref015","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/j.1440-1797.2011.01532.x","article-title":"Development of a non-targeted metabolomics method to investigate urine in a rat model of polycystic kidney disease","volume":"17","author":"H Abbiss","year":"2012","journal-title":"Nephrology (Carlton)"},{"issue":"4","key":"pone.0233213.ref016","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy","volume":"19","author":"I Rowe","year":"2013","journal-title":"Nat Med"},{"issue":"11","key":"pone.0233213.ref017","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ki.2011.30","article-title":"Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine","volume":"79","author":"W Gronwald","year":"2011","journal-title":"Kidney Int"},{"issue":"3","key":"pone.0233213.ref018","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1053\/j.ajkd.2013.10.011","article-title":"Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease","volume":"63","author":"E Meijer","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"8901","key":"pone.0233213.ref019","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(94)92026-5","article-title":"Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1","volume":"343","author":"D Ravine","year":"1994","journal-title":"Lancet"},{"issue":"9","key":"pone.0233213.ref020","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"AS Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"pone.0233213.ref021","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/mrc.1941","article-title":"A 1H-NMR thermometer suitable for cryoprobes","volume":"45","author":"M Findeisen","year":"2007","journal-title":"Magn Reson Chem"},{"issue":"1","key":"pone.0233213.ref022","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jmr.2005.05.018","article-title":"Rapid pulse length determination in high-resolution NMR","volume":"176","author":"PS Wu","year":"2005","journal-title":"J Magn Reson"},{"issue":"1","key":"pone.0233213.ref023","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0006-291X(80)90695-6","article-title":"A two-dimensional nuclear Overhauser enhancement (2D NOE) experiment for the elucidation of complete proton-proton cross-relaxation networks in biological macromolecules","volume":"95","author":"A Kumar","year":"1980","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"pone.0233213.ref024","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1054\/brst.1999.0053","article-title":"Hot-water bottle induced thermal injury of the skin overlying Becker's mammary prosthesis.","volume":"8","author":"RK Price","year":"1999","journal-title":"Breast"},{"key":"pone.0233213.ref025","doi-asserted-by":"crossref","first-page":"D801","DOI":"10.1093\/nar\/gks1065","article-title":"HMDB 3.0\u2014The Human Metabolome Database in 2013","volume":"41","author":"DS Wishart","year":"2013","journal-title":"Nucleic Acids Res"},{"key":"pone.0233213.ref026","doi-asserted-by":"crossref","first-page":"D402","DOI":"10.1093\/nar\/gkm957","article-title":"BioMagResBank","volume":"36","author":"EL Ulrich","year":"2008","journal-title":"Nucleic Acids Res"},{"key":"pone.0233213.ref027","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.aca.2018.07.070","article-title":"KIMBLE: A versatile visual NMR metabolomics workbench in KNIME","volume":"1044","author":"A Verhoeven","year":"2018","journal-title":"Anal Chim Acta"},{"issue":"13","key":"pone.0233213.ref028","doi-asserted-by":"crossref","first-page":"4281","DOI":"10.1021\/ac051632c","article-title":"Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics","volume":"78","author":"F Dieterle","year":"2006","journal-title":"Anal Chem"},{"issue":"19","key":"pone.0233213.ref029","first-page":"2010","article-title":"Effect of Lanreotide on Kidney Function in Patients With Autosomal Dominant Polycystic Kidney Disease: The DIPAK 1","volume":"320","author":"E Meijer","year":"2018","journal-title":"Randomized Clinical Trial. JAMA"},{"issue":"15","key":"pone.0233213.ref030","first-page":"1","article-title":"Effect Displays in R for Generalised Linear Models","volume":"8","author":"J Fox","year":"2003","journal-title":"Journal of Statistical Software"},{"issue":"1","key":"pone.0233213.ref031","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1681\/ASN.2013101138","article-title":"Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials","volume":"26","author":"MV Irazabal","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"pone.0233213.ref032","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1146\/annurev.nu.06.070186.003023","article-title":"Metabolism and function of myo-inositol and inositol phospholipids","volume":"6","author":"BJ Holub","year":"1986","journal-title":"Annu Rev Nutr"},{"issue":"12","key":"pone.0233213.ref033","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/ndt\/gfy020","article-title":"Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate","volume":"33","author":"RB Gil","year":"2018","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"pone.0233213.ref034","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ijcard.2010.11.003","article-title":"Urinary asymmetric dimethylarginine (ADMA) is a predictor of mortality risk in patients with coronary artery disease","volume":"156","author":"C Wolf","year":"2012","journal-title":"Int J Cardiol"},{"issue":"1","key":"pone.0233213.ref035","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/path.2769","article-title":"Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF-beta1 synthesis","volume":"223","author":"F Mihout","year":"2011","journal-title":"J Pathol"},{"issue":"4","key":"pone.0233213.ref036","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/ki.1990.265","article-title":"Renal handling of citrate","volume":"38","author":"LL Hamm","year":"1990","journal-title":"Kidney Int"},{"issue":"2","key":"pone.0233213.ref037","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ndt\/gfu044","article-title":"Metabolic abnormalities in autosomal dominant polycystic kidney disease","volume":"30","author":"Z Mao","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"pone.0233213.ref038","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.03250410","article-title":"Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease","volume":"6","author":"VE Torres","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"pone.0233213.ref039","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.cca.2016.05.018","article-title":"Changes in serum metabolites with the stage of chronic kidney disease: Comparison of diabetes and non-diabetes","volume":"459","author":"J Lee","year":"2016","journal-title":"Clin Chim Acta"},{"issue":"6","key":"pone.0233213.ref040","first-page":"644","article-title":"Proton NMR spectra of urine as indicators of renal damage. Mercury-induced nephrotoxicity in rats","volume":"27","author":"JK Nicholson","year":"1985","journal-title":"Mol Pharmacol"},{"key":"pone.0233213.ref041","article-title":"Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease","author":"ASL Yu","year":"2019","journal-title":"Kidney Int"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233213","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T13:30:17Z","timestamp":1590154217000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0233213"}},"subtitle":[],"editor":[{"given":"Tatsuo","family":"Shimosawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,5,22]]},"references-count":41,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,5,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0233213","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,22]]}}}